Vaccination equally enables both genetically susceptible and resistant mice to control infection with group A streptococci

Microbes and Infection

Volumn 8, Issue 2, 2006, Pages 347-353

  Siegert, Jeannette ^a   Sastalla, Inka ^a   Chhatwal, Gursharan Singh ^a   Medina, Eva ^a  

^a HELMHOLTZ CENTRE FOR INFECTION RESEARCH   (Germany)

Author keywords

Genetic resistance susceptibility; Group A streptococci; Vaccination

Indexed keywords

BACTERIAL PROTEIN; BACTERIUM ANTIBODY; IMMUNOGLOBULIN A; IMMUNOGLOBULIN G ANTIBODY; PROTEIN M1; STREPTOCOCCUS VACCINE; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BACTERIAL IMMUNITY; COMPARATIVE STUDY; CONTROLLED STUDY; EXPERIMENTAL INFECTION; FEMALE; GENETIC SUSCEPTIBILITY; IMMUNOCOMPETENCE; INFECTION CONTROL; INFECTION RESISTANCE; MOUSE; MOUSE STRAIN; NONHUMAN; PRIORITY JOURNAL; STREPTOCOCCUS AGALACTIAE; STREPTOCOCCUS INFECTION; T LYMPHOCYTE; VACCINATION;

ANIMALS; ANTIBODIES, BACTERIAL; ANTIGENS, BACTERIAL; BACTERIAL OUTER MEMBRANE PROTEINS; CARRIER PROTEINS; DISEASE MODELS, ANIMAL; FEMALE; GENETIC PREDISPOSITION TO DISEASE; IMMUNOGLOBULIN A, SECRETORY; IMMUNOGLOBULIN G; MICE; MICE, INBRED BALB C; MICE, INBRED C3H; MICE, NUDE; STREPTOCOCCAL INFECTIONS; STREPTOCOCCAL VACCINES; STREPTOCOCCUS PYOGENES; VACCINATION;

ANIMALIA; BACTERIA (MICROORGANISMS); STREPTOCOCCUS; STREPTOCOCCUS AGALACTIAE; STREPTOCOCCUS SP. 'GROUP A';

EID: 32244440765     PISSN: 12864579     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.micinf.2005.06.024     Document Type: Article

References (31)

1. M.W. Cunningham Pathogenesis of group A streptococcal infections Clin. Microbiol. Rev. 13 2000 470 511
2. E.L. Kaplan The resurgence of group A streptococcal infections and their sequelae Eur. J. Clin. Microbiol. Infect. Dis. 10 1991 55 57
3. D.E. Low, B. Schwartz, and A. McGeer The reemergence of severe group A streptococcal disease: an evolutionary perspective 1998 American Society for Microbiology Press Washington, DC
4. D.M. Musher, R.J. Hamill, C.E. Wright, J.E. Clarridge, and C.M. Ashton Trends in bacteremic infection due to Streptococcus pyogenes (group A streptococcus), 1986-1995 Emerg. Infect. Dis. 2 1996 54 56
5. A.L. Bisno Non-suppurative poststreptococcal sequelae: rheumatic fever and glomerulonephritis G.L. Mandell J.E. Bennett R. Dolin Principles and Practice of Infectious Diseases 1995 Churchill Livingstone New York 1799 1810
6. M.A. Gerber, and R.R. Tanz New approaches to the treatment of group A streptococcal pharyngitis Curr. Opin. Pediatr. 13 2001 51 55
7. S. Chatellier, N. Ihendyane, R.G. Kansal, F. Khambaty, H. Basma, A. Norrby-Teglund, D.E. Low, A. McGeer, and M. Kotb Genetic relatedness and superantigen expression in group A streptococcus serotype M1 isolates from patients with severe and nonsevere invasive diseases Infect. Immun. 68 2000 3523 3534
8. M. Kotb, A. Norrby-Teglund, A. McGeer, H. El-Sherbini, M.T. Dorak, A. Khurshid, K. Green, J. Peeples, J. Wade, G. Thomson, B. Schwartz, and D.E. Low An immunogenetic and molecular basis for differences in outcomes of invasive group A streptococcal infections Nat. Med. 8 2002 1398 1404
9. A. Norrby-Teglund, S. Chatellier, D.E. Low, A. McGeer, K. Green, and M. Kotb Host variation in cytokine responses to superantigens determine the severity of invasive group A streptococcal infection Eur. J. Immunol. 30 2000 3247 3255
10. A. Norrby-Teglund, R. Lustig, and M. Kotb Differential induction of Th1 versus Th2 cytokines by group A streptococcal toxic shock syndrome isolates Infect. Immun. 65 1997 5209 5215
11. E. Medina, O. Goldmann, M. Rohde, A. Lengeling, and G.S. Chhatwal Genetic control of susceptibility to group A streptococcal infection in mice J. Infect. Dis. 184 2001 846 852
12. O. Goldmann, G.S. Chhatwal, and E. Medina Immune mechanisms underlying host susceptibility to infection with group A streptococci J. Infect. Dis. 187 2003 854 861
13. E. Medina, and R.J. North Resistance ranking of some common inbred mouse strains to Mycobacterium tuberculosis and relationship to major histocompatibility complex haplotype and Nramp1 genotype Immunology 93 1998 270 274
14. E. Medina, and R.J. North Genetically susceptible mice remain proportionally more susceptible to tuberculosis after vaccination Immunology 96 1999 16 21
15. M. Rasmussen, H.P. Müller, and L. Björck Protein GRAB of Streptococcus pyogenes regulates proteolysis at the bacterial surface by binding α2-macroglobulin J. Biol. Chem. 274 1999 15336 15344
16. J. Sambrook E.F. Fritsch T. Maniatis Molecular Cloning: A Laboratory Manual, second ed 1989 Cold Spring Harbor Laboratory Press Cold Spring Harbor, NY
17. H. Basma, A. Norrby-Teglund, Y. Guedez, A. McGeer, D.E. Low, O. El-Ahmedy, B. Schwartz, and M. Kotb Risk factors in the pathogenesis of invasive group A streptococcal infections: role of protective humoral immunity Infect. Immun. 67 1999 1871 1877
18. S.E. Holm, A. Norrby, A.M. Bergholm, and M. Norgren Aspects of pathogenesis of serious group A streptococcal infections in Sweden, 1988-1989 J. Infect. Dis. 166 1992 31 37
19. H.S. Courtney, D.L. Hasty, and J.B. Dale Serum opacity factor (SOF) of Streptococcus pyogenes evokes antibodies that opsonize homologous and heterologous SOF-positive serotypes of group A streptococci Infect. Immun. 71 2003 5097 5103
20. D. Bessen, and V.A. Fischetti Passive acquired mucosal immunity to group A streptococci by secretory immunoglobulin A J. Exp. Med. 167 1988 1945 1950
21. V.A. Fischetti, W.M. Hodges, and D.E. Hruby Protection against streptococcal pharyngeal colonization with a vaccinia: M protein recombinant Science 244 1989 1487 1490
22. J. Holmgren, C. Czerkinsky, N. Lycke, and A.M. Svennerholm Mucosal immunity: implications for vaccine development Immunobiology 184 1992 157 179
23. J.R. McGhee, J. Mestecky, M.T. Dertzbaugh, J.H. Eldridge, M. Hirasawa, and H. Kiyono The mucosal immune system: from fundamental concepts to vaccine development Vaccine 10 1992 75 88
24. P.P. Cleary, E.L. Kaplan, J.P. Handley, A. Wlazlo, M.H. Kim, A.R. Hauser, and P.M. Schlievert Clonal basis for resurgence of serious Streptococcus pyogenes disease in the 1980s Lancet 339 1992 518 521
25. B.K. Eriksson, J. Andersson, S.E. Holm, and M. Norgren Invasive group A streptococcal infections: T1M1 isolates expressing pyrogenic exotoxins A and B in combination with selective lack of toxin-neutralizing antibodies are associated with increased risk of streptococcal toxic shock syndrome J. Infect. Dis. 180 1999 410 418
26. S. Avrameas Natural autoantibodies: from 'horror autotoxicus' to 'gnothi seauton' Immunol. Today 12 1991 154 159
27. A.F. Ochsenbein, and R.M. Zinkernagel Natural antibodies and complement link innate and acquired immunity Immunol. Today 21 2000 624 630
28. A.F. Ochsenbein, T. Fehr, C. Lutz, M. Suter, F. Brombacher, H. Hengartner, and R.M. Zinkernagel Control of early viral and bacterial distribution and disease by natural antibodies Science 286 1999 2156 2159
29. D.E. Briles, M. Nahm, K. Schroer, J. Davie, P. Baker, J. Kearney, and R. Barletta Antiphosphocholine antibodies found in normal mouse serum are protective against intravenous infection with type 3 streptococcus pneumoniae J. Exp. Med. 153 1981 694 705
30. L.M. Mahieu, S.E. Holm, H.J. Goossens, and K.J. van Acker Congenital streptococcal toxic shock syndrome with absence of antibodies against streptococcal pyrogenic exotoxins J. Pediatr. 127 1995 987 989
31. E.M. Mascini, M. Jansze, J.F. Schellekens, J.M. Musser, J.A. Faber, L.A. Verhoef-Verhage, L. Schouls, W.J. van Leeuwen, J. Verhoef, and H. van Dijk Invasive group A streptococcal disease in the Netherlands: evidence for a protective role of anti-exotoxin A antibodies J. Infect. Dis. 181 2000 631 638